Beneficient (BENF) presents a deeply negative liquidation posture as of December 31, 2025. Total assets of $337.9 million face total liabilities of $375.9 million at face value, producing a GAAP deficit before noncontrolling interests. The MFFAIS-computed liquidation value is reported at negative $92.5 million, consistent with the balance-sheet arithmetic. Under liquidation lens haircuts, the asset side deteriorates further: the primary asset is alternative investment NAV of $173.2 million (held in consolidated Customer ExAlt Trusts), which is collateral for ExAlt Loans. These LP interests are illiquid, transfer-restricted, and require GP consent to sell — a liquidation haircut well below NAV is warranted, likely 40-60 cents on the dollar given market discount and transfer constraints. The $56.2 million derivative asset and $55.0 million in other assets (largely the $34.5 million insurance recovery receivable offsetting the GWG settlement liability) are contingent and non-cash; under liquidation the insurance offset nets to zero but the $34.5 million liability in accounts payable remains at face. Cash is $7.9 million, at 100% recovery. Goodwill of $9.9 million and indefinite-lived intangibles of $3.1 million recover at zero. The allowance for credit losses on ExAlt Loans ($390.6 million against $578.1 million gross) is an internal valuation reserve, not an external creditor claim, but reflects management's assessment that 67.6% of the loan book is impaired — this is a structural signal, not a liability. The dominant liability risks are: (1) HCLP loan ($94.4 million principal plus $26.8 million accrued interest = approximately $121 million, in default as of April 14, 2025, with HCLP asserting the full amount immediately due); (2) the arbitration award of approximately $66.2 million (including post-judgment interest) confirmed by the Texas Fifth Court of Appeals on October 10, 2025; and (3) Bradley Capital accrued payable of $6.1 million. The Company has disclosed substantial doubt about its ability to continue as a going concern. Operating cash burn was $34.7 million for the nine months ended December 31, 2025. Compared to the prior period (September 30, 2025 10-Q): the allowance for credit losses increased from approximately $342.5 million to $390.6 million, the Customer ExAlt Trust alternative asset NAV declined from $259.1 million to $173.2 million (a $85.9 million reduction driven by asset sales and value erosion), and the HCLP accrued interest grew from $24.0 million to $26.8 million. The filing discusses the $66.2 million arbitration award accrual, unfunded capital commitments of $31.0 million, and the Asset Sales Initiative ($50.4 million in gross proceeds through February 11, 2026) in MD&A but several of these contingent obligations are not separately XBRL-tagged beyond general accrued liabilities.
▼ Community Notes